On Tiffany Cunningham’s Appointment to the CAFC: An Impeccable Candidate and a Rallying Call for More Diversity in IP – In a post on IPWatchDog, Emer Simic writes about Tiffany Cunningham, whose “confirmation [is] now imminent” and has “reached [a] historic milestone.”
Federal Circuit Resumes In-Person Argument With $1.2 Billion Cancer Drug Case – Scott Graham commented on the oral argument in Juno Therapeutics Inc v. Kite Pharma Inc., in which Chief Judge Moore “pressed [attorneys] repeatedly on whether . . . [a] patent on a groundbreaking approach to cancer treatment . . . [is] sufficiently described.”
FBI Agent Who Fought VA for GI Bill College Benefits Wins Appeal; Case Could Help Vets Nationwide – In the Chicago Sun Times, Stephanie Zimmermann discusses Rudisill v. McDonough, where Jim Rudisill’s “successful legal battle could result in additional benefits for other long-serving veterans.”
Pentagon Cancels JEDI Cloud Contract After Years of Contentious Litigation – Jared Serbu, deputy editor of FederalNewsNetwork.com, reports that the “bitterly contentious saga over what was once envisioned [as] the largest information technology procurements . . . finally came to an end . . . as Defense officials said they would no longer pursue the [Joint Enterprise Defense infrastructure] JEDI Cloud contract.”
On Tiffany Cunningham’s Appointment to the CAFC: An Impeccable Candidate and a Rallying Call for More Diversity in IP
Reported by Emer Simic on IPWatchDog.com
On IPWatchDog, Emer Simic authored a post about Tiffany Cunningham, the “first African American to sit on the Federal Circuit,” commenting that “Cunningham’s confirmation is also notable in that it adds another woman to the federal bench.” Additionally, Simic notes, Cunningham’s “elevation to the Federal Circuit can and should inspire law firms . . . to make sure that diverse lawyers obtain more experience in senior litigation roles.” Simic says that “we also owe a responsibility to better educate diverse students.”
Federal Circuit Resumes In-Person Argument With $1.2 Billion Cancer Drug Case
Reported by Scott Graham on Law.com
Scott Graham posted an article on Law.com stating that in Juno Therapeutics Inc v. Kite Pharma Inc. a $1.2 billion judgment is “at stake.” Graham describes the case as involving “willful infringement of a patent that helped pave the way for CAR-T therapy,” which may “’possibly [cure] cancer.’” Graham highlights that in the in-person oral argument, Chief Judge Moore “indicated she believes the patent claims weren’t sufficiently described—a recurring roadblock for biologic drugs at the Federal Circuit.”
FBI agent Who Fought VA for GI Bill College Benefits Wins Appeal; Case Could Help Vets Nationwide
Reported by Stephanie Zimmermann on Chicago.SunTimes.com
Stephanie Zimmermann wrote an article for the Chicago Sun Times focusing on the long terms effects of Rudisill v. McDonough. Zimmermann explains that Rudisill “won a court fight regarding veterans’ benefits that could result in improved government-paid benefits for many of the nation’s longest-serving veterans who want to further their education.” Zimmerman notes that the ruling by the Federal Circuit “could mean the VA would have to pay benefits collectively worth potentially billions of dollars to long-serving veterans.”
Pentagon Cancels JEDI Cloud Contract After Years of Contentious Litigation
Reported by Jared Serbu on FederalNewsNetwork.com
On FederalNewsNetwork.com, Jared Serbu reported on Oracle America, Inc. v. United States, a recent decision by the Federal Circuit that he says was “long in coming” but “not altogether unexpected.” Serbu explains that this case “brings an end to a procurement process that’s been intensely contested almost since its conception.” Serbu notes that “Defense officials said they would no longer pursue the JEDI Cloud contract . . . [and have] begun procedures to cancel the solicitation entirely, and to terminate the contested award to Microsoft.”